BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7817704)

  • 21. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient platelet and HLA antibody formation in multitransfused patients with malignancy.
    McGrath K; Wolf M; Bishop J; Veale M; Ayberk H; Szer J; Cooper I; Whiteside M
    Br J Haematol; 1988 Mar; 68(3):345-50. PubMed ID: 3355793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological screening, using three different test systems of platelet-transfused patients with hematologic-oncologic disorders.
    Wernet D; Schnaidt M; Mayer G; Northoff H
    Vox Sang; 1993; 65(2):108-13. PubMed ID: 8212664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of the Platelet Refractory Patient.
    Forest SK; Hod EA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):665-77. PubMed ID: 27113003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
    Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
    Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors.
    Vox Sang; 2003 Jan; 84(1):73-88. PubMed ID: 12542737
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions.
    Murphy MF; Metcalfe P; Ord J; Lister TA; Waters AH
    Br J Haematol; 1987 Nov; 67(3):255-60. PubMed ID: 3689693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support.
    Sanz C; Freire C; Alcorta I; Ordinas A; Pereira A
    Transfusion; 2001 Jun; 41(6):762-5. PubMed ID: 11399816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antibodies in multiple transfused patients.
    Lam CP; Chow MP
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Dec; 50(6):439-42. PubMed ID: 1338018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Test for anti-platelet antibody].
    Kurata Y
    Rinsho Byori; 1989 Jul; 37(7):750-5. PubMed ID: 2691734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA antibodies--the cause of platelet alloimmunization in Chinese.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin JS; Lin WM; Lin CK
    Am J Hematol; 1992 Jan; 39(1):15-9. PubMed ID: 1536138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of red blood cell and platelet allo-antibodies in platelet alloimmunized patients].
    Moncharmont P; Rigal D
    Transfus Clin Biol; 2014 Jun; 21(3):99-102. PubMed ID: 24948207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens.
    Saito S; Ota S; Seshimo H; Yamazaki Y; Nomura S; Ito T; Miki J; Ota M; Fukushima H; Maeda H
    Transfusion; 2002 Mar; 42(3):302-8. PubMed ID: 11961234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of anti-platelet antibodies using flow cytometry].
    Tsubaki K
    Rinsho Byori; 1993 Sep; 41(9):998-1006. PubMed ID: 8254978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological aspects of platelet transfusions.
    Murphy MF; Waters AH
    Br J Haematol; 1985 Jul; 60(3):409-14. PubMed ID: 4015986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.